المؤلفون: Shefner JM; Barrow Neurological Institute, University of Arizona, and Creighton University, Phoenix, AZ, USA., Al-Chalabi A; King's College London, London, UK., Andrews JA; The Neurological Institute of New York, Columbia University Irving Medical Center, New York, NY, USA., Chio A; Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy., De Carvalho M; Department of Neurosciences of Centro Hospitalar Universitário Lisboa-Norte, Faculty of Medicine, Centro de Estudos Egas Moniz, Institute of Molecular Medicine, Universidade de Lisboa, Lisbon, Portugal., Cockroft BM; Sangamo Therapeutics, Inc, Brisbane, CA, USA., Corcia P; Centre de Réference SLA, CHU Bretonneau, Tours, France., Couratier P; Neurology Department, LS Centre CHU Dupuytren, Limoges, France., Cudkowicz ME; Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, MA, USA., Genge A; Montreal Neurological Institute, Montreal, QC, Canada., Hardiman O; Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland., Heiman-Patterson T; Neurology Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA., Henderson RD; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia., Ingre C; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden., Jackson CE; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Johnston W; University of Alberta, Edmonton, AB, Canada., Lechtzin N; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ludolph A; UULM Clinic of Neurology, Ulm University, Ulm, Germany., Maragakis NJ; Johns Hopkins ALS Clinical Trials Unit, Johns Hopkins University, Baltimore, MD, USA., Miller TM; Washington University School of Medicine, St. Louis, MO, USA., Mora Pardina JS; ALS Unit, Hospital Universitario San Rafael, Madrid, Spain., Petri S; Department of Neurology, Hannover Medical School, Hannover, Germany., Simmons Z; Penn State Health Milton S Hershey Medical Center, Hershey, PA, USA., Van Den Berg LH; Department of Neurology, UMC Utrecht Brain Center, Netherlands ALS Centre, University Medical Center Utrecht, Utrecht, Netherlands., Zinman L; Sunnybrook Health Sciences Centre, Toronto, ON, Canada, and., Kupfer S; Cytokinetics, Incorporated, South San Francisco, CA, USA., Malik FI; Cytokinetics, Incorporated, South San Francisco, CA, USA., Meng L; Cytokinetics, Incorporated, South San Francisco, CA, USA., Simkins TJ; Cytokinetics, Incorporated, South San Francisco, CA, USA., Wei J; Cytokinetics, Incorporated, South San Francisco, CA, USA., Wolff AA; Cytokinetics, Incorporated, South San Francisco, CA, USA., Rudnicki SA; Cytokinetics, Incorporated, South San Francisco, CA, USA.

المصدر: Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2023 Aug; Vol. 24 (5-6), pp. 523-534. Date of Electronic Publication: 2023 May 30.

نوع المنشور: Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101587185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2167-9223 (Electronic) Linking ISSN: 21678421 NLM ISO Abbreviation: Amyotroph Lateral Scler Frontotemporal Degener Subsets: MEDLINE

مواضيع طبية MeSH: Amyotrophic Lateral Sclerosis*/diagnosis , Amyotrophic Lateral Sclerosis*/drug therapy , Courage*, Humans ; Double-Blind Method ; Probability ; Disease Progression

المؤلفون: Gebrehiwet P; Cytokinetics, Incorporated, South San Francisco, CA, USA., Meng L; Cytokinetics, Incorporated, South San Francisco, CA, USA., Rudnicki SA; Cytokinetics, Incorporated, South San Francisco, CA, USA., Sarocco P; Cytokinetics, Incorporated, South San Francisco, CA, USA., Wei J; Cytokinetics, Incorporated, South San Francisco, CA, USA., Wolff AA; Cytokinetics, Incorporated, South San Francisco, CA, USA., Chiò A; Rita Levi Montalcini Department of Neuroscience, University of Turin, Turin, Italy., Andrews JA; The Neurological Institute, Columbia University, New York, NY, USA., Genge A; Montreal Neurological Institute, Montreal, QC, Canada., Jackson CE; University of Texas Health Science Center, San Antonio, TX, USA., Lechtzin N; Johns Hopkins School of Medicine, Baltimore, MD, USA., Miller TM; Washington University School of Medicine, St. Louis, MO, USA., Shefner JM; Barrow Neurological Institute, Phoenix, AZ, USA.

المصدر: Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2023 May; Vol. 24 (3-4), pp. 304-310. Date of Electronic Publication: 2022 Dec 12.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101587185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2167-9223 (Electronic) Linking ISSN: 21678421 NLM ISO Abbreviation: Amyotroph Lateral Scler Frontotemporal Degener Subsets: MEDLINE

مواضيع طبية MeSH: Amyotrophic Lateral Sclerosis*/diagnosis , Amyotrophic Lateral Sclerosis*/drug therapy, Humans ; Retrospective Studies ; Disease Progression ; Outcome Assessment, Health Care

المؤلفون: Gebrehiwet P; Cytokinetics, Incorporated, South San Francisco, CA, USA., Meng L; Cytokinetics, Incorporated, South San Francisco, CA, USA., Rudnicki SA; Cytokinetics, Incorporated, South San Francisco, CA, USA., Sarocco P; Cytokinetics, Incorporated, South San Francisco, CA, USA., Wei J; Cytokinetics, Incorporated, South San Francisco, CA, USA., Wolff AA; Cytokinetics, Incorporated, South San Francisco, CA, USA., Butzner M; Cytokinetics, Incorporated, South San Francisco, CA, USA., Chiò A; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy., Andrews JA; The Neurological Institute of New York, Columbia University Irving Medical Center, New York, NY, USA., Genge A; Clinical Research Unit, Montreal Neurological Institute-Hospital, Montreal, QC, Canada., Hughes DA; Centre for Health Economics & Medicines Evaluation, School of Medical and Health Sciences, Bangor University, Bangor, UK., Jackson CE; Department of Neurology, University of Texas Health Science Center at San Antonio, TX, USA., Lechtzin N; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Miller TM; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA., Shefner JM; Barrow Neurological Institute, University of Arizona, Phoenix, AZ, USA.; Department of Neurology, Creighton University, Phoenix, AZ, USA.

المصدر: Journal of medical economics [J Med Econ] 2023 Jan-Dec; Vol. 26 (1), pp. 488-493.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

مواضيع طبية MeSH: Amyotrophic Lateral Sclerosis*/drug therapy, Humans ; Quality-Adjusted Life Years ; Surveys and Questionnaires ; Double-Blind Method ; Quality of Life

المؤلفون: Rudnicki SA; Cytokinetics, Incorporated, South San Francisco, CA, USA., Andrews JA; The Neurological Institute, Columbia University, New York, NY, USA., Genge A; Montreal Neurological Institute, Montreal, QC, Canada., Jackson C; Departments of Neurology and Otolaryngology, University of Texas Health Science Center, San Antonio, TX, USA., Lechtzin N; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA., Miller TM; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA., Cockroft BM; Cytokinetics, Incorporated, South San Francisco, CA, USA., Malik FI; Cytokinetics, Incorporated, South San Francisco, CA, USA., Meng L; Cytokinetics, Incorporated, South San Francisco, CA, USA., Wei J; Cytokinetics, Incorporated, South San Francisco, CA, USA., Wolff AA; Cytokinetics, Incorporated, South San Francisco, CA, USA., Shefner JM; Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA.

مؤلفون مشاركون: FORTITUDE-ALS STUDY GROUP

المصدر: Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2022 May; Vol. 23 (3-4), pp. 263-270. Date of Electronic Publication: 2021 Jul 05.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101587185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2167-9223 (Electronic) Linking ISSN: 21678421 NLM ISO Abbreviation: Amyotroph Lateral Scler Frontotemporal Degener Subsets: MEDLINE

مواضيع طبية MeSH: Amyotrophic Lateral Sclerosis*/drug therapy, Humans ; Disease Progression ; Double-Blind Method ; Durable Medical Equipment ; Prescriptions

المؤلفون: Shefner JM; Barrow Neurological Institute, Phoenix, AZ, USA., Andrews JA; The Eleanor and Lou Gehrig ALS Center, The Neurological Institute, New York, NY, USA., Genge A; Montreal Neurological Institute, Montreal, QC, Canada., Jackson C; University of Texas Health Science Center, San Antonio, TX, USA., Lechtzin N; Johns Hopkins School of Medicine, Baltimore, MD, USA., Miller TM; Washington University School of Medicine, St. Louis, MO, USA., Cockroft BM; Cytokinetics, Inc, South San Francisco, CA, USA., Meng L; Cytokinetics, Inc, South San Francisco, CA, USA., Wei J; Cytokinetics, Inc, South San Francisco, CA, USA., Wolff AA; Cytokinetics, Inc, South San Francisco, CA, USA., Malik FI; Cytokinetics, Inc, South San Francisco, CA, USA., Bodkin C; Indiana University School of Medicine, Indianapolis, IN, USA., Brooks BR; Atrium Health Neurosciences Institute-Carolinas Neuromuscular/ALS MDA Care Center, Charlotte, NC, USA., Caress J; Wake Forest Health Sciences, Winston-Salem, NC, USA., Dionne A; CHU de Québec, Université Laval, Quebec, Canada., Fee D; Medical College of Wisconsin, Milwaukee, WI, USA., Goutman SA; University of Michigan, Ann Arbor, MI, USA., Goyal NA; The ALS & Neuromuscular Center, UCI Health, Orange, CA, USA., Hardiman O; Trinity College, Beaumont Hospital, Dublin, Ireland., Hayat G; St. Louis University, St. Louis, MO, USA., Heiman-Patterson T; Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA., Heitzman D; Texas Neurology, Dallas, TX, USA., Henderson RD; Royal Brisbane and Women's Hospital, Herston, Australia., Johnston W; University of Alberta, Edmonton, AB, Canada., Karam C; Oregon Health & Science University, Portland, OR, USA., Kiernan MC; Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia., Kolb SJ; Wexner Medical Center, Ohio State University, Columbus, OH, USA., Korngut L; University of Calgary, Calgary, AB, Canada., Ladha S; St. Joseph's Hospital and Medical Center, Neurological Institute, AZ, USA Barrow Phoenix., Matte G; Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Mora JS; Hospital San Rafael, Madrid, Germany., Needham M; Perron Institute, Department of Neurology, Fiona Stanley Hospital, The University of Notre Dame Australia, Murdoch University, Perth, Australia., Oskarsson B; Mayo Clinic Florida, Jacksonville, FL, USA., Pattee GL; Neurology Associates, Lincoln, NE, USA., Pioro EP; Cleveland Clinic, Cleveland, OH, USA., Pulley M; University of Florida, Jacksonville, FL, USA., Quan D; University of Colorado Denver, Aurora, CO, USA., Rezania K; University of Chicago Medical Center, Chicago, IL, USA., Schellenberg KL; University of Saskatchewan, Saskatoon, SK, Canada., Schultz D; Flinders Medical Centre, Bedford Park, Australia., Shoesmith C; London Health Sciences Centre, London, ON, Canada., Simmons Z; Penn State Hershey Medical Center, Hershey, PA, USA., Statland J; University of Kansas Medical Center, Kansas City, KS, USA., Sultan S; West Virginia University, Morgantown, WV, USA., Swenson A; University of Iowa, Iowa City, IA, USA., Berg LHVD; Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands., Vu T; University of South Florida, Tampa, FL, USA., Vucic S; Westmead Hospital, Sydney, Australia., Weiss M; University of Washington, Seattle, WA, USA., Whyte-Rayson A; Duke University School of Medicine, Durham, NC, USA., Wymer J; University of Florida, Gainesville, FL, USA., Zinman L; ALS/Neuromuscular Clinic Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Rudnicki SA; Cytokinetics, Inc, South San Francisco, CA, USA.

المصدر: Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2021 May; Vol. 22 (3-4), pp. 287-299. Date of Electronic Publication: 2020 Sep 24.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101587185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2167-9223 (Electronic) Linking ISSN: 21678421 NLM ISO Abbreviation: Amyotroph Lateral Scler Frontotemporal Degener Subsets: MEDLINE

مواضيع طبية MeSH: Amyotrophic Lateral Sclerosis*/drug therapy, Double-Blind Method ; Humans ; Muscle Strength